These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9531187)

  • 1. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
    Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
    Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoximine.
    Torres VE; Bengal RJ; Litwiller RD; Wilson DM
    J Am Soc Nephrol; 1997 Aug; 8(8):1283-91. PubMed ID: 9259355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats.
    Cowley BD; Ricardo SD; Nagao S; Diamond JR
    Kidney Int; 2001 Dec; 60(6):2087-96. PubMed ID: 11737583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
    Aukema HM; Housini I
    Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
    Keith DS; Torres VE; Johnson CM; Holley KE
    Am J Kidney Dis; 1994 Sep; 24(3):491-8. PubMed ID: 8079975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease.
    Wiedmeyer CE; Royal AB
    Comp Med; 2010 Dec; 60(6):448-54. PubMed ID: 21262131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-dependent effect of L-NAME on polycystic kidney disease in Han:SPRD rats.
    Yoshida I; Bengal R; Torres VE
    Am J Kidney Dis; 2000 May; 35(5):930-6. PubMed ID: 10793029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azotemia and extrarenal manifestations in old female Han:SPRD (cy/+) rats.
    Kränzlin B; Schieren G; Gretz N
    Kidney Int; 1997 Apr; 51(4):1160-9. PubMed ID: 9083282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
    Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
    Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
    Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
    Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saskatoon berry supplementation prevents cardiac remodeling without improving renal disease in an animal model of reno-cardiac syndrome.
    Raj P; Louis XL; Yu L; Siow YL; Suh M; Aukema HM; Netticadan T
    J Food Biochem; 2021 Oct; 45(10):e13893. PubMed ID: 34459008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of disease progression in rats with inherited polycystic kidney disease.
    Cowley BD; Grantham JJ; Muessel MJ; Kraybill AL; Gattone VH
    Am J Kidney Dis; 1996 Jun; 27(6):865-79. PubMed ID: 8651252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dietary flaxseed supplementation on organic anion and osmolyte content and excretion in rat polycystic kidney disease.
    Ogborn MR; Nitschmann E; Bankovic-Calic N; Buist R; Peeling J
    Biochem Cell Biol; 1998; 76(2-3):553-9. PubMed ID: 9923725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cystic disease and ammoniagenesis in Han:SPRD rats.
    Torres VE; Mujwid DK; Wilson DM; Holley KH
    J Am Soc Nephrol; 1994 Nov; 5(5):1193-200. PubMed ID: 7873729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender hormones and the progression of experimental polycystic kidney disease.
    Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
    Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.